Alnylam Pharmaceuticals
ALNY
#1148
Rank
A$29.52 B
Marketcap
A$220.41
Share price
-3.17%
Change (1 day)
-67.39%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company